Yisheng Pharmaceutical (002566): Foreign Investment Rating (FIR)
Yisheng Pharmaceutical (002566) Annual Report Review: Higher Costs and Lower Net Profit 2016 Back on Track
[Soochow Securities] Yisheng Pharmaceutical Co., Ltd.: the cost is high and the net profit is low, 2016 is back on track
Yisheng Pharmaceutical Co., Ltd. (002566): the cosmetics business exceeds expectations and has a lot of room for the growth of Standard Snow Flower Show.
Yisheng Pharmaceutical Industry (002566): the value of the whole industry chain of ginseng has been improved.
Yisheng Pharmaceutical (002566) comments: China report results to good ginseng and cosmetics business is expected to bring annual results higher than expected
[Huachuang Securities] Yisheng Pharmaceutical Industry: the construction of Ginseng slices Industrial Park is about to start, and the business of ginseng and cosmetics is expected to lead to better-than-expected performance.
Yisheng Pharmaceutical Industry (002566) comments: ginseng slices Industrial Park is about to start construction of ginseng, cosmetics business is expected to bring better-than-expected performance
[Hongyuan Securities] Yisheng Pharmaceutical Industry: steady growth of the pharmaceutical industry, acquisition and participation in the industry to expand the industrial chain
[Minsheng Securities] Yisheng Pharmaceutical Industry: ginseng leader is just growing up
Yisheng Pharmaceutical (002566) Dynamic Report: Ginseng Leaders Are Beginning to Grow
Yisheng Pharmaceutical (002566): Acquire Huangfeng to participate in the business to consolidate the ginseng business segment
【华创证券】益盛药业:收购皇封参业,夯实人参业务板块
益盛药业(002566)2014年季报点评:长期判断不变、且看饮片放量
【中航证券】益盛药业2014年季度报告点评:长期判断不变,且看饮片放量
【华安证券】益盛药业:人参价格上涨,饮片项目启动
益盛药业(002566)公司研究报告:药业稳定、参业长远
【中航证券】益盛药业:药业稳定、参业长远
益盛药业(002566):中药、人参、蜂蜜三轮驱动
【光大证券】益盛药业:中药、人参、蜂蜜三轮驱动
No Data
No Data